SOCIETAL CDMO, INC. Financial Statements (2024 and earlier)
Company Profile
| Business Address |
1 E. UWCHLAN AVE, SUITE 112 EXTON, PA 19341 |
| State of Incorp. | PA |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 14,995 | 25,217 | 23,760 | 19,148 | 38,514 | 64,482 | |||
| Cash and cash equivalents | 14,995 | 25,217 | 23,760 | 19,148 | 38,514 | 60,984 | |||
| Short-term investments | 3,498 | ||||||||
| Receivables | 15,950 | 11,913 | 9,033 | 14,389 | 12,866 | 9,686 | |||
| Inventory, net of allowances, customer advances and progress billings | 10,301 | 8,917 | 11,612 | 15,072 | 10,699 | 9,839 | |||
| Inventory | 10,301 | 8,917 | 11,612 | 15,072 | 10,699 | 9,839 | |||
| Contract with customer, asset, after allowance for credit loss | 8,724 | 8,565 | 7,330 | 8,851 | 5,201 | ✕ | |||
| Disposal group, including discontinued operation | 2,768 | ||||||||
| Other undisclosed current assets | 2,848 | 2,917 | 2,334 | 2,700 | 3,861 | 3,276 | |||
| Total current assets: | 55,586 | 57,529 | 54,069 | 60,160 | 71,141 | 87,283 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 5,491 | 5,924 | 485 | ✕ | ✕ | ||||
| Property, plant and equipment | 50,365 | 51,708 | 43,841 | 42,212 | 45,640 | 39,074 | |||
| Intangible assets, net (including goodwill) | 44,005 | 44,910 | 5,019 | 7,602 | 38,712 | 41,296 | |||
| Goodwill | 41,077 | 41,077 | 4,319 | 4,319 | 6,446 | 6,446 | |||
| Intangible assets, net (excluding goodwill) | 2,928 | 3,833 | 700 | 3,283 | 32,266 | 34,850 | |||
| Deferred tax assets, net | ✕ | ✕ | ✕ | ✕ | ✕ | 18,573 | |||
| Other undisclosed noncurrent assets | 1,996 | 246 | 486 | ||||||
| Total noncurrent assets: | 101,857 | 102,788 | 49,346 | 50,299 | 84,352 | 98,943 | |||
| TOTAL ASSETS: | 157,443 | 160,317 | 103,415 | 110,459 | 155,493 | 186,226 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 14,152 | 2,085 | 6,329 | 5,165 | 18,675 | 17,851 | |||
| Accounts payable | 1,466 | 2,085 | 1,804 | 989 | 4,510 | 7,954 | |||
| Accrued liabilities | 12,686 | 4,525 | 4,176 | 14,165 | 9,897 | ||||
| Debt | 7,577 | 1,474 | 148 | ||||||
| Disposal group, including discontinued operation | 1,172 | ||||||||
| Business combination, contingent consideration, liability | 10,354 | 32,053 | |||||||
| Due to related parties | ✕ | 2,039 | |||||||
| Other undisclosed current liabilities | 1,079 | 13,611 | |||||||
| Total current liabilities: | 22,808 | 17,735 | 7,803 | 6,485 | 29,029 | 49,904 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 30,967 | 97,059 | 108,097 | 110,686 | 64,243 | 53,598 | |||
| Long-term debt, excluding current maturities | 30,967 | 92,127 | 108,097 | 110,319 | 64,243 | 53,598 | |||
| Liabilities, other than long-term debt | 6,334 | 3,369 | 1,248 | 80,558 | 50,360 | ||||
| Deferred revenue | 1,248 | ✕ | ✕ | ||||||
| Lease deposit liability | 1,750 | ✕ | ✕ | ||||||
| Due to related parties | ✕ | 3,369 | |||||||
| Operating lease, liability | 4,584 | 4,932 | 367 | ✕ | ✕ | ||||
| Business combination, contingent consideration, liability | 80,558 | 50,360 | |||||||
| Other undisclosed noncurrent liabilities | 37,475 | 90 | 367 | 1,163 | 3,516 | ||||
| Total noncurrent liabilities: | 74,776 | 100,518 | 109,712 | 110,686 | 145,964 | 107,474 | |||
| Total liabilities: | 97,584 | 118,253 | 117,515 | 117,171 | 174,993 | 157,378 | |||
| Equity | |||||||||
| Equity, attributable to parent | 59,859 | 42,064 | (14,100) | (6,712) | (19,500) | 28,848 | |||
| Preferred stock | 4,350 | ||||||||
| Common stock | 846 | 467 | 286 | 233 | 218 | 191 | |||
| Additional paid in capital | 320,298 | 287,351 | 219,998 | 199,938 | 168,535 | 140,006 | |||
| Accumulated other comprehensive loss | (1) | ||||||||
| Accumulated deficit | (265,635) | (245,754) | (234,384) | (206,883) | (188,253) | (111,348) | |||
| Total equity: | 59,859 | 42,064 | (14,100) | (6,712) | (19,500) | 28,848 | |||
| TOTAL LIABILITIES AND EQUITY: | 157,443 | 160,317 | 103,415 | 110,459 | 155,493 | 186,226 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 90,214 | 75,360 | 66,499 | 99,219 | 77,347 | 71,834 | ||
| Cost of revenue | (67,076) | (55,537) | (54,134) | (53,097) | (46,676) | (46,177) | ||
| Cost of goods and services sold | (67,076) | (55,537) | (54,134) | (50,981) | (43,160) | (38,193) | ||
| Gross profit: | 23,138 | 19,823 | 12,365 | 46,122 | 30,671 | 25,657 | ||
| Operating expenses | (22,859) | (19,411) | (20,707) | (22,492) | (84,714) | (65,968) | ||
| Operating income (loss): | 279 | 412 | (8,342) | 23,630 | (54,043) | (40,311) | ||
| Nonoperating income | 512 | 385 | ||||||
| Investment income, nonoperating | 512 | 385 | ||||||
| Interest and debt expense | (19,055) | (11,782) | (19,159) | (19,806) | (8,756) | (12,034) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | (18,776) | (11,370) | (27,501) | 3,824 | (62,287) | (51,960) | ||
| Other undisclosed income from continuing operations before income taxes | 19,806 | |||||||
| Income (loss) from continuing operations before income taxes: | (18,776) | (11,370) | (27,501) | 23,630 | (62,287) | (51,960) | ||
| Income tax expense (benefit) | (1,105) | 677 | 7,135 | (1,012) | (17,436) | 1,880 | ||
| Income (loss) from continuing operations: | (19,881) | (10,693) | (20,366) | 22,618 | (79,723) | (50,080) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | (10,693) | (20,366) | (637) | (79,723) | (50,080) | |
| Loss from discontinued operations | (23,255) | |||||||
| Other undisclosed net loss | (677) | (7,135) | (17,993) | |||||
| Net loss available to common stockholders, diluted: | (19,881) | (11,370) | (27,501) | (18,630) | (79,723) | (50,080) | ||
Comprehensive Income ($ in thousands)
| 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (19,881) | (11,370) | (27,501) | (18,630) | (79,723) | (50,080) | ||
| Other comprehensive income (loss) | 1 | (1) | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (19,881) | (11,370) | (27,501) | (18,630) | (79,722) | (50,081) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.